MedTrace Logo

Heart Rate Vs. Race Pace-Based Prescription Training in Recreational Distance Runners

NCT07109089 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2025-08-07

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to compare adherence to training prescription-defined as the percentage of time spent within the prescribed intensity zone-using either a race pace-based method or a heart rate-based method in male and female recreational distance runners.

The main research questions are:

* Which training prescription method leads to greater adherence in recreational runners?
* Which method results in more accurate execution of low- and high-intensity interval training sessions?

Participants will undergo anthropometric and physiological assessments to determine training zones based on ventilatory thresholds. In addition, a 5-km time trial will be performed on a standard track to establish individual race pace zones.

Conditions

  • Exercise Response
  • Physical Fitness
  • Athletic Performance
  • Running Endurance

Interventions

OTHER

Race Pace-based training

Participants complete one week of endurance training based on race pace zones individually determined from a 5-km time trial performance. The program includes both low-intensity continuous runs and high-intensity interval training sessions.

OTHER

Heart Rate-Based Training

Participants complete one week of endurance training based on heart rate zones individually determined from ventilatory threshold assessments. The program includes both low-intensity continuous runs and high-intensity interval training sessions.

Sponsors & Collaborators

  • Universidad Rey Juan Carlos

    lead OTHER

Principal Investigators

  • Arturo Casado, PhD · Universidad Rey Juan Carlos

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2024-07-30
Completion
2025-01-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07109089 on ClinicalTrials.gov